Africa NAD+ Supplements Market Industry Trends and Forecast to 2034: Segmented by (Ingredient, Form, Distribution Channel, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Overview
Market Dashboard
Africa · 2024–2034 · placeholder estimates
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the
full report.
Estimate 2024$8.2 MnPlaceholder estimate
Estimate 2025$9.2 Mn1.5% of the global market
Projected 2034$26.2 Mn 184.1%Adds $16.9 Mn over 9 forecast years
CAGR 2025–203412.3%Faster than 88% of 82 OTC & Nutraceuticals markets here
Key players5Companies profiled
Africa is 1.49% of the global market.
Among regions, the largest is North America at $274.6 Mn.
Fastest growing: Africa (this report) at 12.3% a year.
Africa ranks 6th of 6 by size among regions.
Market size projection
Africa
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
Value added each year
$16.9 Mn total, 2026–2034
Year-by-year market size, 2024–2034
NAD+ Supplements Market market size by year, Africa
Year
Market size
Change that year
Since 2025
2024 (estimate)
$8.2 Mn
—
—
2025 (base)
$9.2 Mn
+$1.0 Mn
—
2026 (forecast)
$10.3 Mn
+$1.1 Mn
+12.3%
2027 (forecast)
$11.6 Mn
+$1.3 Mn
+26.1%
2028 (forecast)
$13.0 Mn
+$1.4 Mn
+41.6%
2029 (forecast)
$14.6 Mn
+$1.6 Mn
+59%
2030 (forecast)
$16.4 Mn
+$1.8 Mn
+78.6%
2031 (forecast)
$18.5 Mn
+$2.0 Mn
+100.6%
2032 (forecast)
$20.7 Mn
+$2.3 Mn
+125.2%
2033 (forecast)
$23.3 Mn
+$2.6 Mn
+153%
2034 (forecast)
$26.2 Mn
+$2.9 Mn
+184.1%
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
1 in AfricaSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Africa. Retrieved 12 Nov 2026.
Formats
PDF, PPTX, XLSX
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
The Africa NAD+ Supplements Market Analysis Executive Summary
NAD+ supplements, such as NMN and nicotinamide riboside, aim to raise levels of NAD+, a molecule linked to cell energy that falls with age.
Key segments of the NAD+ Supplements market include ingredient (Nicotinamide Riboside, NMN and NAD+ Direct) and form (Capsules, Powders and IV and Injections).
Africa NAD+ Supplements market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.
Africa NAD+ Supplements Market Dynamics
Market Growth Drivers
An ageing population, longer life expectancy, rising interest in healthy ageing and new science on how the body ages are driving the NAD+ Supplements market. Older adults and their families are spending more on staying active and independent.
Opportunity
Preventive care, personalised plans based on biomarkers and home-based services give the NAD+ Supplements market room to grow, especially in fast-ageing countries in Asia and Europe.
Market Restraints
Limited clinical proof for some longevity products, high out-of-pocket costs, regulation that does not treat ageing as a disease and uneven access hold back the NAD+ Supplements market.
Competitive Landscape for NAD+ Supplements Market in Africa
The NAD+ Supplements market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Healthcare Policies and Regulatory Landscape for NAD+ Supplements Market in Africa
NAD+ Supplements in Africa: rules and research
The African Medicines Agency (AMA), set up by an African Union treaty in force since November 2021, aims to bring the work of national regulators together.[1] In some of the countries we cover here, medicines are approved by EDA (Egypt)[2], PPB (Kenya)[3] and SAHPRA (South Africa)[4]. In some of the countries we cover here, supplement rules come from EDA and NFSA (Egypt)[2], PPB (Kenya)[5] and SAHPRA (South Africa)[4]. ClinicalTrials.gov lists 1 study on NAD+ Supplements that is recruiting, active or about to start in Africa.[6]
[6]ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Africa. Retrieved 12 Nov 2026.
Policy changes and Reimbursement scenario
Food and supplement rules, labelling and health-claim regulations govern NAD+ Supplements products. Authorities such as the US FDA, EFSA and national food safety bodies set what can be sold and claimed in Africa.
2.2 Market Size, Growth Prospects and Key findings
3 Market Dynamics
3.1 Market Growth Drivers Analysis
3.2 Market Restraints Analysis
4 Market Segmentation
4.1 By Ingredient
4.2 By Form
4.3 By Distribution Channel
5 By Market Share
5.1 Market Analysis, Insights and Forecast – By Revenue
6 Competitive Landscape
6.1 Major Top Market Players Products in Pipeline
6.2 R&D Initiatives
6.3 Notable recent Deals
6.3.1 Strategic Divestments
6.3.2 Mergers & Acquisitions
6.3.3 Partnerships
6.3.4 Joint Ventures
7 Key Company Profiles
7.1 ChromaDex
7.2 Elysium Health
7.3 Thorne
7.4 Life Extension
7.5 Renue By Science
8 Healthcare Policies and Regulatory Landscape
8.1 Policy changes and Reimbursement scenario
8.2 Government Initiatives / Intervention programs
The NAD+ Supplements market can be segmented based on various criteria, including ingredient, form and distribution channel. Here's a breakdown of the market segmentation
What doctors and scientists are doing in NAD+ Supplements right now, from free public sources.
Clinical trials
1 active trial in Egypt, South Africa, Kenya, Nigeria, Ethiopia, DR Congo, Uganda, Tanzania, Niger, Mozambique, Sudan, Malawi, Zambia, Mali, Burkina Faso, Ghana and Morocco
Recruiting, about to start, or running now. Counted across the 17 countries we report on in Africa.
Sources:PubMed (US National Library of Medicine),
ClinicalTrials.gov,
WHO Global Health Observatory.
Fetched 15 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
Placeholder estimate: about $9.2 Mn in 2025, rising to about $26.2 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the NAD+ Supplements market in Africa growing?
Placeholder estimate: about 12.3% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the NAD+ Supplements market report cover?
The report splits the market by ingredient (Nicotinamide Riboside, NMN, NAD+ Direct, Combination Formulas), form (Capsules, Powders, IV and Injections) and distribution channel (Supermarkets and Hypermarkets, Pharmacies and Drug Stores, Online Retail, Specialty Stores).
Who are the key players in the NAD+ Supplements market?
Key players include ChromaDex, Elysium Health, Thorne, Life Extension and Renue By Science.
What is driving the NAD+ Supplements market?
An ageing population, longer life expectancy, rising interest in healthy ageing and new science on how the body ages are driving the NAD+ Supplements market. Older adults and their families are spending more on staying active and independent.
Who regulates NAD+ Supplements in Africa?
The African Medicines Agency (AMA), set up by an African Union treaty in force since November 2021, aims to bring the work of national regulators together. Source: African Union, African Medicines Agency treaty. Checked 14 Nov 2026.
How many clinical trials on NAD+ Supplements are running in Africa?
1 study is recruiting, active or about to start in Africa, counted across the 17 countries we report on there, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Africa. Retrieved 12 Nov 2026.
How much research is published on NAD+ Supplements?
PubMed lists 1,091 papers on NAD+ Supplements added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.